| Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, Northern California, USA, March–April 2020 J Ferguson, JI Rosser, O Quintero, J Scott, A Subramanian, M Gumma, ... Emerging infectious diseases 26 (8), 1679, 2020 | 93 | 2020 |
| Covid-19 vaccination: evidence of waning immunity is overstated J Scott, A Richterman, M Cevik Bmj 374, 2021 | 42 | 2021 |
| Treatment optimization for HIV/HCV co-infected patients JA Scott, KW Chew Therapeutic advances in infectious disease 4 (1), 18-36, 2017 | 30 | 2017 |
| Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: the ACTIV-6 randomized clinical trial TG Stewart, PA Rebolledo, A Mourad, CJ Lindsell, DR Boulware, ... Jama 330 (24), 2354-2363, 2023 | 28 | 2023 |
| Covid-19 vaccines, immunity, and boosters A Richterman, J Scott, M Cevik Bmj 375, 2021 | 24 | 2021 |
| Use of biomarkers to individualize antimicrobial therapy duration: a narrative review J Scott, S Deresinski Clinical Microbiology and Infection 29 (2), 160-164, 2023 | 23 | 2023 |
| Recurrent Multifocal Mycoplasma orale Infection in an Immunocompromised Patient: A Case Report and Review J Ketchersid, J Scott, T Lew, N Banaei, S Kappagoda Case Reports in Infectious Diseases 2020 (1), 8852115, 2020 | 11 | 2020 |
| Human immunodeficiency virus/acquired immunodeficiency syndrome in older adults J Scott, MB Goetz Clinics in geriatric medicine 32 (3), 571-583, 2016 | 6 | 2016 |
